ArticleThe American journal of managed care2023
Influence of prior authorization requirements on provider clinical decision-making.
Article in The American journal of managed care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- The Triple Burden of Administrative Tasks Among US Family Medicine Physicians-A Cross-sectional Study.Journal of general internal medicine · 2026Article
- Medicare Advantage Prior-Authorizations Are Linked to Racial Differences in End-of-Life Home Health Use.Journal of the American Geriatrics Society · 2026Article
- Article
- GLP-1RA Dispensing in Youth With Type 2 Diabetes: 2020 to 2023.Pediatrics · 2026Article
- Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity.BMJ open diabetes research & care · 2026Review
- Insurance Noncoverage of Interventional Pain Procedures: Paving the Road Toward the Second Prescription Opioid Crisis.Journal of pain research · 2026Article
- Supporting complex mental health care and services research today and beyond: a mini-review of real-world evidence strategies and informed approaches.Frontiers in health services · 2026Review
- Understanding long-acting injectables in the context of treatment planning for schizophrenia: crafting a strategy.CNS spectrums · 2025Review
- Evaluation of Payer Policies to Reduce Low-Value Medical Device-Based Procedure Use.JAMA health forum · 2025Article
- Prior Authorization of Medication and Its Influence on Provider Behavior: Latent Class Analysis.Journal of medical Internet research · 2025Article
- Perceived Timeliness of Prior Authorization Approvals for Medicaid Home- and Community-Based Services.Journal of the American Geriatrics Society · 2025Article
- State-level variation in access to long-acting injectable antiretroviral therapy for HIV in the United States.Health affairs scholar · 2025Article
- The Burden of Insurance Prior Authorization on Cancer Care: A Review of Evidence From Radiation Oncology.Advances in radiation oncology · 2025Review
- An Overview of the Challenging Process of Prior Authorization: Medical Necessity for a Better Way.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024Article
- The Patient's Journey in Obesity within the United States: An Exercise of Resilience against Disease.Life (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesPrior authorization (PA) aims to promote the safe and effective use of medications and to control costs. However, PA-related administrative tasks can contribute to burden on health care providers. This study examines how such tasks affect treatment decisions. STUDY
designCross-sectional, online survey.
methodsWe conducted an online survey of US medical providers in 2020 based on a convenience sample of 100,000 providers. Multivariate path analysis was used to examine associations among provider practice characteristics, step therapy and other health plan requirements, perceived burdens of PA, communication issues with insurers, and prescribing behaviors (prescribing a different medication than planned, avoiding prescribing of newer medications even if evidence-based guideline recommendations are met, and modifying a diagnosis). Weighted analyses were conducted to assess nonresponse bias.
resultsA total of 1173 respondents (1.2% response rate) provided 1147 usable surveys. Step therapy requirements had the largest effect on clinical decision-making. Other significant effects on clinical decision-making included perceived PA likelihood, communication issues, and health plan requirements (eg, clinical documentation). Weighted analyses showed that the study conclusions were unlikely to have been biased by nonresponse.
conclusionsRespondents report that they may alter clinical decisions to avoid PA requirements and related burdens, even in cases in which use of the PA medication was clinically appropriate. Processes that reduce the administrative burden of PA through improved communication and transparency as well as standardized documentation may help ensure that PA more seamlessly achieves its goals of safe and effective use of medications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.